A report from Timothy Anderson at Sanford C. Bernstein examines what will happen to Big Pharma after patents, like the loss of Lipitor from Pfizer and Zyprexa from Eli Lilly, will expire.
A report from Timothy Anderson at Sanford C. Bernstein examines what will happen to Big Pharma after patents, like the loss of Lipitor from Pfizer and Zyprexa from Eli Lilly, will expire.